Literature DB >> 10477907

Regulation of prostatic stromal cell growth and function by transforming growth factor beta (TGFbeta).

H C Klingler1, A J Bretland, S V Reid, C R Chapple, C L Eaton.   

Abstract

BACKGROUND: The majority of the overgrowth in benign prostatic hyperplasia (BPH) specimens is comprised of connective tissue. Factors that control stromal growth in the prostate are poorly understood; however, members of the transforming growth factor beta (TGFbeta) family may be of particular importance in the etiology of BPH.
METHODS: Thirty-two low-passage stromal cultures were generated from human prostatectomy specimens. Their stromal origin was confirmed and expression of TGFbetas analyzed by duplex reverse transcription-polymerase chain reaction (RT-PCR). Challenge experiments were designed to study the effects of exogenous TGFbeta1 on stromal cell growth and synthesis of extracellular matrix components.
RESULTS: The expression of TGFbetas 1, 2, and 3 was demonstrated in all 32 cell strains. The stromal origin of the cell lines was confirmed. Exogenous TGFbeta1 added to stromal cultures resulted in inhibition of cell growth and increased production of type I collagen.
CONCLUSIONS: The prostatic stromal cell strains we have developed are a reliable mod- el for investigating prostatic connective tissue biology. The challenge experiments with TGFbeta1 provide further evidence for the involvement of TGFbetas in prostatic enlargement, as modulators of the extracellular matrix in the absence of growth stimulation. Copyright 1999 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10477907     DOI: 10.1002/(sici)1097-0045(19991001)41:2<110::aid-pros5>3.0.co;2-x

Source DB:  PubMed          Journal:  Prostate        ISSN: 0270-4137            Impact factor:   4.104


  8 in total

1.  Characteristics of a human prostate stromal cell line related to its use in a stromal-epithelial coculture model for the study of cancer chemoprevention.

Authors:  Lena Diaw; Mark Roth; Debra A Schwinn; Mary E d'Alelio; Lisa J Green; Joseph A Tangrea
Journal:  In Vitro Cell Dev Biol Anim       Date:  2005 May-Jun       Impact factor: 2.416

2.  Mechanisms of prostate atrophy after LHRH antagonist cetrorelix injection: an experimental study in a rat model of benign prostatic hyperplasia.

Authors:  Dong Yang; Teng Hou; Xiong Yang; Yan Ma; Longwang Wang; Bing Li
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2012-06-09

Review 3.  Growth factors in benign prostatic hyperplasia: basic science implications.

Authors:  M Scott Lucia; James R Lambert
Journal:  Curr Urol Rep       Date:  2008-07       Impact factor: 3.092

4.  Dual regulation of proliferation and growth arrest in prostatic stromal cells by transforming growth factor-beta1.

Authors:  Wei Zhou; Irwin Park; Michael Pins; James M Kozlowski; Borko Jovanovic; Ju Zhang; Chung Lee; Kenneth Ilio
Journal:  Endocrinology       Date:  2003-07-24       Impact factor: 4.736

5.  Benign prostatic hyperplasia: from bench to clinic.

Authors:  Tag Keun Yoo; Hee Ju Cho
Journal:  Korean J Urol       Date:  2012-03-19

6.  Increased CK5/CK8-positive intermediate cells with stromal smooth muscle cell atrophy in the mice lacking prostate epithelial androgen receptor.

Authors:  Yuanjie Niu; Juan Wang; Zhiqun Shang; Shu-Pin Huang; Chih-Rong Shyr; Shuyuan Yeh; Chawnshang Chang
Journal:  PLoS One       Date:  2011-07-06       Impact factor: 3.240

7.  Specific expression pattern of tissue cytokines analyzed through the Surface Acoustic Wave technique is associated with age-related spontaneous benign prostatic hyperplasia in rats.

Authors:  Maria M Rivera Del Alamo; Mireia Díaz-Lobo; Silvia Busquets; Joan E Rodríguez-Gil; Josep M Fernández-Novell
Journal:  Biochem Biophys Rep       Date:  2018-04-02

8.  Alternative splicing of TGF-betas and their high-affinity receptors T beta RI, T beta RII and T beta RIII (betaglycan) reveal new variants in human prostatic cells.

Authors:  Lutz Konrad; Jonas A Scheiber; Elke Völck-Badouin; Marcel M Keilani; Leslie Laible; Heidrun Brandt; Ansgar Schmidt; Gerhard Aumüller; Rainer Hofmann
Journal:  BMC Genomics       Date:  2007-09-11       Impact factor: 3.969

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.